Phase I trial of RAD001 (R) and docetaxel (D) in castration resistant prostate cancer (CRPC) with FDG-PET assessment of RAD001 activity

Abstract only

Saved in:

Bibliographic Details
Published in	Journal of clinical oncology Vol. 26; no. 15_suppl; p. 5069
Main Authors	Ross, R. W., Manola, J., Oh, W. K., Ryan, C., Kim, J., Rastarhuyeva, I., Yap, J. T., Van Den Abbeele, A. D., Kantoff, P. W., Taplin, M.
Format	Journal Article
Language	English
Published	20.05.2008
Online Access	Get full text

Loading…